News Releases

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The study from MGH Cancer Center researchers identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

Hitting where it hurts

Exploiting cancer cell 'addiction' may lead to new therapies

01/Jun/2009

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The study from MGH Cancer Center researchers identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

 

Link to full Cell Press release.

Media Contacts: Katie Marquedant, 617 726-0337, kmarquedant@partners.org

patient

U.S. News and World Report Best Hospitals 2012-2013

U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.

  • © 2013 Massachusetts General Hospital
  • 617-726-2000
  • TDD: 617-724-8800

Site Map

  • Partners Healthcare
  • Harvard Medical School
  • Massachusetts General Physicians Organization
  • MassGeneral Hospital for Children
  • Individual Care, Global Impact: The Campaign for the Third Century of MGH Medicine
  • Proto